BioRem
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.132.736.7411.183.14-11.879.9924.928.447.19N/A-4.36
Price/Sales ratio
0.180.270.230.750.600.740.851.320.470.62N/A0.67
Price/Book Value ratio
-7.542.391.522.341.131.311.5416.453.012.33N/A1.22
Price/Cash Flow ratio
-4.372.15-4.7414.58-5.81K6.116.258.549.4331.98N/A-2.90K
Price/Free Cash Flow ratio
-4.092.15-4.6714.76-62.986.466.978.7210.97-249.40N/A-28.26
Price/Earnings Growth ratio
0.00-0.01-0.090.860.010.09-0.03-0.750.040.17N/A0.05
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
20.88%35.51%25.83%27.79%26.21%23.55%28.78%25.47%30.35%27.90%N/A24.88%
Operating Profit Margin
-10.72%13.02%5.18%6.77%7.05%-4.95%11.15%8.45%9.14%12.16%N/A1.04%
Pretax Profit Margin
-16.12%10.00%3.44%6.78%7.05%-4.96%10.97%8.31%8.25%11.08%N/A1.04%
Net Profit Margin
-16.12%10.00%3.44%6.78%19.17%-6.30%8.56%5.3%5.58%8.66%N/A6.43%
Effective Tax Rate
-33.46%30.15%50.73%-3.68%-171.93%-26.94%21.91%36.22%32.32%21.86%N/A-99.43%
Return on Assets
-22.39%18.17%4.82%9.76%22.16%-7.38%9.51%6.76%7.78%9.05%N/A7.38%
Return On Equity
667.29%87.35%22.54%20.96%36.18%-11.10%15.44%66.04%35.68%32.43%N/A12.53%
Return on Capital Employed
-134.61%113.68%33.99%20.94%13.30%-8.72%19.23%34.87%33.81%30.07%N/A2.29%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
1.011.141.201.772.132.232.211.151.301.41N/A2.18
Cash ratio
0.170.370.120.420.481.091.130.330.290.16N/A0.79
Days of Sales Outstanding
146.99104.97204.68172.04197.11100.55113.86151.10154.79218.71N/A148.83
Days of Inventory outstanding
20.4323.5114.3715.808.7729.7319.8618.0416.1218.12N/A19.25
Operating Cycle
167.43128.48219.06187.84205.88130.28133.72169.14170.92236.84N/A168.08
Days of Payables Outstanding
71.0260.1791.7589.9077.5954.4538.03101.3685.53123.44N/A66.02
Cash Conversion Cycle
96.4068.30127.3097.93128.2975.8295.6967.7885.38113.40N/A102.05
Debt Ratios
Debt Ratio
0.450.300.19N/AN/AN/AN/A0.260.200.12N/AN/A
Debt Equity Ratio
-13.681.480.89N/AN/AN/AN/A2.550.940.44N/AN/A
Long-term Debt to Capitalization
1.30N/AN/AN/AN/AN/AN/A0.640.390.26N/AN/A
Total Debt to Capitalization
1.070.590.47N/AN/AN/AN/A0.710.480.30N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.120.74-0.35N/AN/AN/AN/A0.750.330.16N/AN/A
Company Equity Multiplier
-29.794.804.672.141.631.501.629.754.583.58N/A1.56
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.040.12-0.040.05-0.000.120.130.150.050.01N/A0.06
Free Cash Flow / Operating Cash Flow Ratio
1.060.991.010.9892.330.940.890.970.85-0.12N/A46.64
Cash Flow Coverage Ratio
-0.120.74-0.35N/AN/AN/AN/A0.750.330.16N/AN/A
Short Term Coverage Ratio
-0.180.74-0.35N/AN/AN/AN/A2.501.110.89N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A